Big Data of Small Molecules

Projektinformationen

BDoSM

ID Finanzhilfevereinbarung: 673863

DOI 10.3030/673863

Abgeschlossenes Projekt

EK-Unterschriftsdatum 9 April 2015

Startdatum 1 Mai 2015

Enddatum 31 Oktober 2015

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

HIGHCHEM SRO
Slovakia

Ziel

As Google mapped and photographed the streets and terrain of our planet, the main objective of the project is to map and spectrally fingerprint the small organic molecules of various organisms and introduce to the market a fundamentally new cloud driven compound identification platform.

Our pioneering solution will allow continuous identity assignment of unknown molecules in biologically relevant samples by developing a technologically mature architecture and infrastructure for storage, processing, search, exchange, analysis, data mining and visualization of millions of spectral, structural, chromatographic and biochemical data of small molecules.
Our project will become the world most comprehensive database platform of spectral fingerprints of endogenous metabolites, natural products and environmental contaminants that will allow identification of substances present in biological samples that could not be identified using conventional technology that is a crucial bottleneck in many biotechnological and pharmaceutical applications.

Since the biomedical, pharmaceutical and biotechnology industry in general are constantly detecting numerous unknown compounds and searching for new biomarkers and disease specific targets, our technology platform is direct response to their needs with the prospect of new business opportunities and future growth.

The feasibility study will be important for acquiring additional financing of the project, to review technological solution (most effective and sustainable, without infringing patents, copyrights, and trademarks of third parties), to precise marketing strategy for corporate, small group & individual users, to identify, clarify and protect own inventions, new approaches and new technical solutions. Finally, the Phase 1 outputs will give perfect review on project management plan.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• natural sciences › computer and information sciences › databases
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › computer and information sciences › data science › big data
• natural sciences › chemical sciences › analytical chemistry › mass spectrometry

Programm/Programme

• H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• BIOTEC-5a-2014-1 - SME boosting biotechnology-based industrial processes driving competitiveness and sustainability

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2014

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

HIGHCHEM SRO

• Netto-EU-Beitrag: € 50 000,00
• Adresse: LESKOVA 11 ; 811 04 Bratislava ; Slowakei
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Slovensko › Bratislavský kraj › Bratislavský kraj
• Region: Slovensko › Bratislavský kraj › Bratislavský kraj
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00